Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Assets: 2017-2024

Historic Assets for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $1.1 billion.

  • Arcus Biosciences' Assets fell 25.08% to $974.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $974.0 million, marking a year-over-year decrease of 25.08%. This contributed to the annual value of $1.1 billion for FY2024, which is 5.02% up from last year.
  • Latest data reveals that Arcus Biosciences reported Assets of $1.1 billion as of FY2024, which was up 5.02% from $1.1 billion recorded in FY2023.
  • Arcus Biosciences' Assets' 5-year high stood at $1.6 billion during FY2021, with a 5-year trough of $772.3 million in FY2020.
  • For the 3-year period, Arcus Biosciences' Assets averaged around $1.2 billion, with its median value being $1.1 billion (2024).
  • In the last 5 years, Arcus Biosciences' Assets spiked by 280.23% in 2020 and then decreased by 18.34% in 2022.
  • Over the past 5 years, Arcus Biosciences' Assets (Yearly) stood at $772.3 million in 2020, then soared by 106.14% to $1.6 billion in 2021, then fell by 18.34% to $1.3 billion in 2022, then dropped by 15.77% to $1.1 billion in 2023, then climbed by 5.02% to $1.1 billion in 2024.